At the cellular level, siRNA-mediated silencing of MTA3 expression significantly reduces the viability and migratory capacity of both HepG2 and Hepa1–6 cell lines (39), indicating that MTA3 plays a critical regulatory role in maintaining the malignant phenotype of HCC. The gene discussed is MTA3; the disease is hepatocellular carcinoma.